+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of sex steroids on cardiovascular risk profile in transgender men under gender affirming hormone therapy



Effects of sex steroids on cardiovascular risk profile in transgender men under gender affirming hormone therapy



Endocrinologia, Diabetes Y Nutricion 2019



Gender affirming hormone therapy (HT) in transgender men both improves and impairs several surrogate cardiovascular risk markers. However, few prospective works with long follow-up and control group are available. In this context, this work aimed to assess the changes in the metabolic and cardiovascular risk pattern after 12 months of HT in transgender men. Furthermore, we aimed to investigate early effects on target tissues that may reflect an initial vascular damage. Prospective observational study, including 20 transgender men, attended in the Gender Identity Unit (UIG) of the Hospital Clinic from July 2013 to November 2015. Anthropometric and body composition by dual-energy X-ray absorptiometry (DXA), hormonal, metabolic and coagulation parameters, endothelial dysfunction by flow-mediated dilation (FMD) and intima-media thickness (IMT) by carotid ultrasound, were assessed at baseline, at 6 and 12 months of HT. We observed an impairment of lipid profile, and increase of homocysteine and leucocytes count, as well as changes in body composition with increased total lean mass together with decreased total fat mass. In addition, higher mean-maximum common IMT was observed after 12 months of HT. Our work shows changes in metabolic and inflammatory parameters after HT after short-medium follow-up, which could increase cardiovascular risk in this setting, together with initial evidence of vascular changes.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 066446973

Download citation: RISBibTeXText

PMID: 30704917


Related references

Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review. Clinical Endocrinology 89(6): 700-711, 2018

Gender-Affirming Hormone Therapy for Transgender Men. Clinical Obstetrics and Gynecology 61(4): 687-704, 2018

Gender-Affirming Hormone Therapy for Transgender Females. Clinical Obstetrics and Gynecology 61(4): 705-721, 2018

Clinical pearls of gender-affirming hormone therapy in transgender patients. Mental Health Clinician 7(4): 164-167, 2018

Should Psychiatrists Prescribe Gender-Affirming Hormone Therapy to Transgender Adolescents?. Ama Journal of Ethics 18(11): 1086-1094, 2017

Factors Associated with Gender-Affirming Surgery and Age of Hormone Therapy Initiation Among Transgender Adults. Transgender Health 2(1): 156-164, 2017

Primary care providers' willingness to continue gender-affirming hormone therapy for transgender patients. Family Practice 35(5): 576-581, 2017

Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition. Current Psychiatry Reports 20(12): 110, 2018

Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons. Clinical Chemistry 65(1): 119-134, 2019

Barriers to Gender-Affirming Care for Transgender and Gender Nonconforming Individuals. Sexuality Research and Social Policy 15(1): 48-59, 2018

Role for OBGYNs in Gender-Affirming Surgical Care of Transgender and Gender Nonconforming Individuals. Clinical Obstetrics and Gynecology 61(4): 722-730, 2018

Social anxiety among transgender and gender nonconforming individuals: The role of gender-affirming medical interventions. Journal of Abnormal Psychology 2018, 2018

Guidelines for Gender Affirming Healthcare for Gender Diverse and Transgender Children, Young People and Adults in Aotearoa, New Zealand. New Zealand Medical Journal 131(1487): 86-96, 2018

Colpectomy Significantly Reduces the Risk of Urethral Fistula Formation after Urethral Lengthening in Transgender Men Undergoing Genital Gender Affirming Surgery. Journal of Urology 2018, 2018

Update on Gender-Affirming Treatment for the Transgender Woman. Seminars in Reproductive Medicine 35(5): 442-447, 2018